Explore

Streams

Products

About Index

Index

By TNW

Astellas Venture Management

3039

Astellas Venture Management

Follow us

Also headquartered in Menlo Park

Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing

Built with ❤︎ by Datalicious ©2019
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 11

Portfolio

Portfolio Tracker

Add info

$79,500,000 Venture capital (Series B)

Oncorus scores $79.5 mln Series B

At Verastem, Infinity’s Former Blood Cancer Drug Heads to FDA

Health

$38,600,000 Venture capital (Series C)

,

Effector Raises $38.6M to Advance New Class of Anti-Cancer Drugs

Funding Health Science

£4,000,000 Venture capital (Series A)

,

Oncorus Announces Additional Series A Financing Support From Astellas Venture Management LLC

Funding Health

Verastem Takes a Low-Cost Flier on Infinity’s Blood Cancer Drug

Health Science

$37,000,000 Venture capital (Series B)

, , , +1

Startup targeting protein degradation in cancer raises $37M

$43,000,000 Venture capital (Series B)

Tizona Therapeutics Closes $43M Series B Funding

Health Funding Science

$40,000,000 Venture capital (Series B)

Effector Therapeutics raises $40 million

Science Health Funding

Verastem Sinks as Mesothelioma Study Halted For Futility

Health